175 related articles for article (PubMed ID: 36573219)
1. ARFIP2 Regulates EMT and Autophagy in Hepatocellular Carcinoma in Part Through the PI3K/Akt Signalling Pathway.
Huang K; Lin Y; Wang K; Shen J; Wei D
J Hepatocell Carcinoma; 2022; 9():1323-1339. PubMed ID: 36573219
[TBL] [Abstract][Full Text] [Related]
2. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
[TBL] [Abstract][Full Text] [Related]
3. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis.
Wei R; Xiao Y; Song Y; Yuan H; Luo J; Xu W
J Exp Clin Cancer Res; 2019 Mar; 38(1):112. PubMed ID: 30832706
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K
Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154
[TBL] [Abstract][Full Text] [Related]
5. MST4 negatively regulates the EMT, invasion and metastasis of HCC cells by inactivating PI3K/AKT/Snail1 axis.
Dian MJ; Li J; Zhang XL; Li ZJ; Zhou Y; Zhou W; Zhong QL; Pang WQ; Lin XL; Liu T; Liu YA; Li YL; Han LX; Zhao WT; Jia JS; Xiao SJ; Xiao D; Xia JW; Hao WC
J Cancer; 2021; 12(15):4463-4477. PubMed ID: 34149910
[No Abstract] [Full Text] [Related]
6. XPA serves as an autophagy and apoptosis inducer by suppressing hepatocellular carcinoma in a PI3K/Akt/mTOR dependent manner.
Deng Y; Chen QS; Huang WF; Dai JW; Wu ZJ
J Gastrointest Oncol; 2021 Aug; 12(4):1797-1810. PubMed ID: 34532129
[TBL] [Abstract][Full Text] [Related]
7. GCNT3 Promotes Hepatocellular Carcinoma Progression and EMT by Activating the PI3K/AKT Pathway.
Wang Y; Fang X; Xie H; Wang X
Biochem Genet; 2024 May; ():. PubMed ID: 38789846
[TBL] [Abstract][Full Text] [Related]
8. LACTB Regulates PIK3R3 to Promote Autophagy and Inhibit EMT and Proliferation Through the PI3K/AKT/mTOR Signaling Pathway in Colorectal Cancer.
Xu W; Yu M; Qin J; Luo Y; Zhong M
Cancer Manag Res; 2020; 12():5181-5200. PubMed ID: 32636680
[TBL] [Abstract][Full Text] [Related]
9. SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.
Zhang M; Liu S; Chua MS; Li H; Luo D; Wang S; Zhang S; Han B; Sun C
Cell Death Dis; 2019 Aug; 10(8):612. PubMed ID: 31406106
[TBL] [Abstract][Full Text] [Related]
10. CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma.
Huang D; Cao L; Zheng S
J Exp Clin Cancer Res; 2017 Jan; 36(1):13. PubMed ID: 28093067
[TBL] [Abstract][Full Text] [Related]
11. AKR1B10 inhibits the proliferation and metastasis of hepatocellular carcinoma cells by regulating the PI3K/AKT pathway.
Tian K; Deng Y; Li Z; Zhou H; Yao H
Oncol Lett; 2024 Jan; 27(1):18. PubMed ID: 38034486
[TBL] [Abstract][Full Text] [Related]
12. HSP4 triggers epithelial-mesenchymal transition and promotes motility capacities of hepatocellular carcinoma cells via activating AKT.
Ma P; Tang WG; Hu JW; Hao Y; Xiong LK; Wang MM; Liu H; Bo WH; Yu KH
Liver Int; 2020 May; 40(5):1211-1223. PubMed ID: 32077551
[TBL] [Abstract][Full Text] [Related]
13. PAK3 promotes the metastasis of hepatocellular carcinoma by regulating EMT process.
Gao Z; Zhong M; Ye Z; Wu Z; Xiong Y; Ma J; Chen H; Zhu Y; Yang Y; Zhao Y; Zhang Z
J Cancer; 2022; 13(1):153-161. PubMed ID: 34976179
[No Abstract] [Full Text] [Related]
14. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
[TBL] [Abstract][Full Text] [Related]
15. KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer
Liao H; Zhang L; Lu S; Li W; Dong W
Front Genet; 2022; 13():848926. PubMed ID: 35812733
[No Abstract] [Full Text] [Related]
16. Emodin inhibits invasion and migration of hepatocellular carcinoma cells via regulating autophagy-mediated degradation of snail and β-catenin.
Qin B; Zeng Z; Xu J; Shangwen J; Ye ZJ; Wang S; Wu Y; Peng G; Wang Q; Gu W; Tang Y
BMC Cancer; 2022 Jun; 22(1):671. PubMed ID: 35715752
[TBL] [Abstract][Full Text] [Related]
17. Family with sequence similarity 111 member B contributes to tumor growth and metastasis by mediating cell proliferation, invasion, and EMT via transforming acidic coiled-coil protein 3/PI3K/AKT signaling pathway in hepatocellular carcinoma.
Yang Y; Yan Z; Jiao Y; Yang W; Cui Q; Chen S
Environ Toxicol; 2024 Jan; 39(1):409-420. PubMed ID: 37782700
[TBL] [Abstract][Full Text] [Related]
18. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-148a Inhibits Hepatocellular Carcinoma Cell Growth via Epithelial-to-Mesenchymal Transition and PI3K/AKT Signaling Pathways by Targeting Death Receptor-5.
Zhang N; Zhou J; Zhou Y; Guan F
Appl Biochem Biotechnol; 2022 Jun; 194(6):2731-2746. PubMed ID: 35267120
[TBL] [Abstract][Full Text] [Related]
20. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
